Orthofix International | OFIX - 销售收入



金融业
股票价格
USD
资产
USD 873.02M
现金及等价物
USD 103.81M
销售成本
USD 66.63M
流动资产
USD 446.13M
流动负债
USD 157.01M
债务
USD 137.24M
股息收益率
0
EBIT
USD 6.12M
EBITDA
USD 27.88M
员工
1.09K
EPS每股收益
USD 0.09
股本和储备
USD 429.18M
销售毛利
USD 153.28M
债务利息支出
4.68M
贷款资金
USD 221.59M
市值
USD 348.3M
净收入
USD -2.22M
营业费用
USD 213.79M
营业利润
USD 6.12M
普通股股本
USD 39.83M
PE价格收益
4.17K
税前利润
USD -2.19M
销售收入
USD 219.91M
销售和管理费用
USD 130.35M
股票
USD 184.48M
贸易债权人
USD 63.53M
应收帐款人
USD 135.75M


销售 更改 日
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 153.6M 12.4M 2026-06
Dexcom USD 1.31B 120M 2026-06
EDAP TMS EUR 15.42M 1.54M 2026-03
Globus Medical USD 789.61M 29.76M 2026-06
Inogen USD 74.93M 504K 2024-09
Insulet USD 801.7M 40M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
J&J USD 25.31B 1.21B 2026-06
Medtronic USD 9.8B 0 2026-06
Mesa Laboratories USD 62.84M 5.01M 2024-12
Orthofix International USD 219.91M 14.28M 2025-12
Plus Therapeutics USD 1.03M 339K 2026-03
Smith & Nephew USD 1.6B 1.58B 2026-06
STAAR Surgical USD 93.5M 0 2026-06
Stryker USD 6.6B 600M 2026-06
Tandem Diabetes Care USD 254.6M 7.38M 2026-06
Teleflex USD 570.3M 22M 2026-06
Veracyte USD 150.32M 11.25M 2026-06
Zimmer Biomet Holdings USD 2.18B 90M 2026-06